Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
Research
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
SAN DIEGO, Feb. 05, 2025 - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from KOMET-001, the Phase 2 registra…
News
25 Patient and Provider Groups Applaud Supreme Court Ruling, Though Express Concern About Other Plaintiffs Keeping FDA Authority Challenge Alive
WASHINGTON, D.C., June 13, 2024 – Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, app…